Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review

BACKGROUND: Selective estrogen receptor modulators, such as tamoxifen, reduce breast cancer risk by up to 50% in women at increased risk for breast cancer. Despite tamoxifen’s well-established efficacy, many studies show that most women are not taking up tamoxifen. This systematic literature review...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hered Cancer Clin Pract
Main Authors: Meiser, B., Wong, W. K. T., Peate, M., Julian-Reynier, C., Kirk, J., Mitchell, G.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607482/
https://ncbi.nlm.nih.gov/pubmed/28943990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13053-017-0075-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados